Topics

Companies Related to "Post neoadjuvant cellular dissociation grading based tumour budding" [Most Relevant Company Matches] RSS

08:34 EDT 2nd April 2020 | BioPortfolio

Here are the most relevant search results for "Post neoadjuvant cellular dissociation grading based tumour budding" found in our extensive corporate database of over 50,000 company records.

Showing "Post neoadjuvant cellular dissociation grading based tumour budding" Companies 1–25 of 6,100+

Relevant

The German Breast Group and Celgene Corporation

GBG is a large independent academic network of over 500 study centers in Germany with the world- wide largest experience in conducting neoadjuvant breast cancer trials. Since 1998, with joined forces from AGO-B, over 10.000 patients participated in the neoadjuvant “Gepardo” trial series. GBG has recruited at totality of over 35.000 patients to tr...


Industrial Research Limited - UK

IRL Biopharm is a highly skilled contract manufacturing business focused on developing and manufacturing novel secondary metabolites for our growing number of biotech and pharma clients around the globe.The majority of our clients are US-based innovative biotech/pharma companies.The company had focused over the past two years on developingand manufacturing toxic molecules for attachment to tumour-...

MISSION Therapeutics Ltd

MISSION Therapeutics was founded in 2011 by a team of scientists including Professor Steve Jackson, Dr Niall Martin, Dr Xavier Jacq and Dr Keith Menear, along with founding institutes Cancer Research Technology and Cambridge University. Its activities are based on the research of Professor Steve Jackson, Professor of Biology at the University of Cambridge and Head of Cancer Research UK Laborator...


PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a patented platform for tumour-targeted delivery based on its oncolytic vaccine, enadenotucirev. Enadenotucirev’s unique design allows it to be delivered systemically via intravenous ...

The Washington Post

The Washington Post provides award-winning news and understanding about the politics, policies, personalities and institutions that make Washington, D.C. the world's seat of power, and is a critical tool and information source for those who call Washington, D.C. home. In digital form, The Washington Post combines its world-class journalism with the latest ...

Cellomics Incorporated

Cellomics, Inc. is ushering in the post-genomic era in drug discovery -- the era of the cell. Cellomics believe that understanding how drugs affect cellular processes and cellular pathways in situ is the most biologically reliable route to discovering effective new medicines. Cellomics is the only company that provides complete systems for high content screening based on multiparametric image anal...

Post-n-Track

Post-n-Track is an information logistics provider for healthcare management, enabling payers, providers, health systems and vendors to securely manage, control and optimize the flow of health information. Post-n-Track aligns the business value of information with the appropriate expertise, infrastructure, communication channels, transaction standards, busi...

Post Capital Partners LLC

Post Capital Partners (www.postcp.com) is a private investment firm that makes both minority growth and control investments in companies with a minimum of $10 million of revenue and $2 million of EBITDA. Post Capital primarily employs an “Executive-First” deal sourcing and investment strategy in which they pursue growth capital investments, manag...

BioGenex Laboratories

BioGenex is a post-genomics era leader and pioneer in the industrial scale automation of in situ measurement and characterization of minute changes in DNA, mRNA, protein and cell/tissue morphology, an analysis used across drug discovery, drug development, and diagnostic processes.BioGenex has developed state-of-the art platform technologies to solve many of the challenges faced by post-genomic era...

U.S. Cellular

U.S. Cellular is the fifth-largest full-service wireless carrier in the United States, providing national network coverage and industry-leading innovations designed to elevate the customer experience. The Chicago-based carrier offers coverage where the other carriers don't and a wide range of communication services that enhance consumers’ lives, incre...

naviHealth, Inc.

naviHealth partners with health plans, health systems, accountable care organizations and post-acute providers to manage the entire continuum of post-acute care. The Company utilizes evidence-based protocols and technology-enabled services to optimize care and align all stakeholders. naviHealth has more than 12 years of experience managing post-acute care ...

naviHealth

naviHealth partners with health plans, health systems, accountable care organizations and post-acute providers to manage the entire continuum of post-acute care. We utilize evidence-based protocols and technology enabled services to optimize care and align all stakeholders. naviHealth has over twelve years experience managing post-acute care and currently ...

XDx, Inc.

Based in Brisbane, California, XDx is a molecular diagnostics company focused on the discovery, development and commercialization of noninvasive gene expression-based tests for the monitoring of transplant rejection and autoimmune diseases. The company has developed a proprietary new method for noninvasively monitoring immune system activity by measuring g...

Post Foods, LLC

Post Foods, LLC, a subsidiary of Ralcorp Holdings, is the manufacturer of iconic ready-to-eat cereal brands including Honey Bunches of Oats, Pebbles, Grape-Nuts, Shredded Wheat, Honeycomb, Post Selects, Trail Mix Crunch, and other great tasting cereals. For more information, please visit www.postcereals.com.

PTC Therapeutics, Inc.

PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple th...

The Huffington Post

The Huffington Post is a Pulitzer Prize-winning source of breaking news, features, and entertainment, as well as a highly engaged community for opinion and conversation. The Huffington Post has 50 million monthly unique visitors (comScore November, 2012) posting more than 8 million comments each month. The site has more than 40,000 bloggers -- from politic...

Cellular Research, Inc.

Cellular Research, Inc. is a biotechnology research and development company founded by innovators from Silicon Valley and Stanford University whose mission is to develop revolutionary quantitative biology products. Cellular Research is commercializing research products (including Pixel™, a standalone direct mRNA quantitation platform, and Preciseâ„...

US Post Acute Care LLC

US Post Acute Care is a Management Services Organization providing value-added service to clinical practice groups specializing in the care of patients in the post-acute setting. An organization with a national footprint, US Post Acute Care provides a full array of management services including billing, recruiting, training, compliance, analytics, and practice development. US Post Acute Care stru...

Cytonus Therapeutics Inc.

Cytonus Therapeutics Inc. is a biopharmaceutical company developing a next-generation Adoptive Cellular Transport platform called Cargocytes™. The San Diego-based company’s proprietary Cargocyte™ platform are cellular-engineered transporters of a multiplicity of therapeutic payloads to tissue in a selective, controllable and potent off-the-shelf ...

The Avicena Group

Based in Palo Alto, CA, the Avicena Group, Inc. is a biotechnology company focused on developing and commercializing novel, high-value products that improve the lives of patients through the regulation of critical cellular energy processes. The company has developed a proprietary cellular energy modulation platform and a cellular energy transport platform that allows it to create a portfolio of in...

PTC Therapeutics Inc.

PTC THERAPEUTICS, INC. (PTC) is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC has assembled pro...

Natural Standard

Natural Standard is an international research collaboration that aggregates and synthesizes data on complementary and alternative therapies. Using a comprehensive methodology and reproducible grading scales, information is created that is evidence-based, consensus-based, and peer-reviewed, tapping into the collective expertise of a multidisciplinary Editorial Board. The mission of this collaborati...

Post & Schell

Post & Schell, established in 1968, currently has approximately 165 lawyers in seven offices: Allentown, Harrisburg, Lancaster, Philadelphia, Pittsburgh, Pa., Princeton, N.J. and Washington, D.C. The law firm provides litigation, corporate, transactional, regulatory, compliance, consulting and educational services locally, regionally and nationally t...

Acumen Bioscience Limited

Acumen Bioscience Ltd is a wholly owned subsidiary of TTP Group plc. It provides comprehensive solutions to the drug discovery market, enabling both cell-based and cell-free assays to be carried out at throughputs that meet the demands of screening laboratories. The high information content of every assay gives a direct indication of a compound's therapeutic potential at the cellular and sub-cellu...

Mynosys Cellular Devices, Inc.

California-based Mynosys Cellular Devices is a global ophthalmic technology company dedicated to providing surgeons with innovative solutions that enable procedural excellence. Developers of the U.S. and internationally approved Zepto® Precision Cataract Surgery platform, the company is committed to developing high-quality solutions to assist physicians in delivering the best care to patients....


More From BioPortfolio on "Post neoadjuvant cellular dissociation grading based tumour budding"

Quick Search

Corporate Database Quicklinks